Merlin cooperates with neurofibromin and Spred1 to suppress the Ras-Erk pathway

Yan Cui1, Lin Ma1,2, Stephan Schacke1

  • 1Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), 07745 Jena, Germany.

Human Molecular Genetics
|December 17, 2020
PubMed

Insights

Merlin acts as a selective Ras barrier, blocking Ras from activating the Ras-Erk pathway in Schwann cells. This mechanism contributes to merlin

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • The Ras-Erk pathway is crucial in human tumor development and is frequently overactivated.
  • Neurofibromatosis types 1 and 2 (NF1, NF2) are genetic disorders characterized by Schwann cell tumors.
  • NF1 tumor suppressor neurofibromin is a Ras-GTPase activating protein (Ras-GAP), while NF2 tumor suppressor merlin is a scaffold protein.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which merlin functions as a tumor suppressor.
  • To investigate the interaction of merlin with the Ras-Erk pathway components.
  • To explore the therapeutic potential of targeting the Ras-Erk pathway in NF2-related tumors.

Main Methods:

  • Co-immunoprecipitation assays to study protein interactions.
  • In vitro binding assays to confirm direct protein-protein interactions.
  • Cell proliferation assays on merlin-deficient Schwann cells.
  • Ras-Erk pathway activity assessment.

Main Results:

  • Merlin interacts with the neurofibromin/Spred1 complex and directly binds to Raf1's Ras-binding domain and kinase domain.
  • Merlin functions as a selective Ras barrier, preventing Ras from binding to Raf1.
  • Merlin deficiency leads to increased Ras-Erk pathway activity and Schwann cell proliferation.
  • Suppression of the Ras-Erk pathway inhibits proliferation in merlin-deficient Schwann cells.

Conclusions:

  • Merlin's tumor suppressor activity in NF2 is mediated by its role in selectively blocking Ras-Raf1 interaction, thereby inhibiting the Ras-Erk pathway.
  • Targeting the Ras-Erk pathway is a promising therapeutic strategy for tumors associated with NF2 inactivation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.8K